BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23175427)

  • 1. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.
    Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes.
    Kaneda A; Yagi K
    Cancer Sci; 2011 Jan; 102(1):18-24. PubMed ID: 21159060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancer.
    Takane K; Akagi K; Fukuyo M; Yagi K; Takayama T; Kaneda A
    Cancer Med; 2017 May; 6(5):1023-1035. PubMed ID: 28378457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three DNA methylation epigenotypes in human colorectal cancer.
    Yagi K; Akagi K; Hayashi H; Nagae G; Tsuji S; Isagawa T; Midorikawa Y; Nishimura Y; Sakamoto H; Seto Y; Aburatani H; Kaneda A
    Clin Cancer Res; 2010 Jan; 16(1):21-33. PubMed ID: 20028768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
    Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
    Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers.
    An B; Kondo Y; Okamoto Y; Shinjo K; Kanemitsu Y; Komori K; Hirai T; Sawaki A; Tajika M; Nakamura T; Yamao K; Yatabe Y; Fujii M; Murakami H; Osada H; Tani T; Matsuo K; Shen L; Issa JP; Sekido Y
    Int J Cancer; 2010 Nov; 127(9):2095-105. PubMed ID: 20131317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis.
    Karpinski P; Szmida E; Misiak B; Ramsey D; Leszczynski P; Bebenek M; Sedziak T; Grzebieniak Z; Jonkisz A; Lebioda A; Sasiadek MM
    Mol Carcinog; 2012 Dec; 51(12):1003-8. PubMed ID: 22006538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
    Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
    Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
    McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
    BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The topography of DNA methylation in the non-neoplastic colonic mucosa surrounding colorectal cancers.
    Subramaniam MM; Loh M; Chan JY; Liem N; Lim PL; Peng YW; Lim XY; Yeoh KG; Iacopetta B; Soong R; Salto-Tellez M
    Mol Carcinog; 2014 Feb; 53(2):98-108. PubMed ID: 22911899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer.
    Worthley DL; Whitehall VL; Buttenshaw RL; Irahara N; Greco SA; Ramsnes I; Mallitt KA; Le Leu RK; Winter J; Hu Y; Ogino S; Young GP; Leggett BA
    Oncogene; 2010 Mar; 29(11):1653-62. PubMed ID: 19966864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile.
    Ferracin M; GafĂ  R; Miotto E; Veronese A; Pultrone C; Sabbioni S; Lanza G; Negrini M
    J Pathol; 2008 Apr; 214(5):594-602. PubMed ID: 18241079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
    Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
    Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype.
    Suzuki H; Igarashi S; Nojima M; Maruyama R; Yamamoto E; Kai M; Akashi H; Watanabe Y; Yamamoto H; Sasaki Y; Itoh F; Imai K; Sugai T; Shen L; Issa JP; Shinomura Y; Tokino T; Toyota M
    Carcinogenesis; 2010 Mar; 31(3):342-9. PubMed ID: 19638426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
    Xu M; Yuan L; Wang Y; Chen S; Zhang L; Zhang X
    Pathol Oncol Res; 2021; 27():1609784. PubMed ID: 34366718
    [No Abstract]   [Full Text] [Related]  

  • 19. Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype.
    Gebhard C; Mulet-Lazaro R; Glatz D; Schwarzfischer-Pfeilschifter L; Schirmacher P; Gaedcke J; Weichert W; Reuschel E; Dietmaier W; Rehli M
    Int J Cancer; 2022 Feb; 150(4):617-625. PubMed ID: 34591983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.
    Frazier ML; Xi L; Zong J; Viscofsky N; Rashid A; Wu EF; Lynch PM; Amos CI; Issa JP
    Cancer Res; 2003 Aug; 63(16):4805-8. PubMed ID: 12941799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.